Executive Director and Head of DMPK @ Gossamer Bio (September 2020 - May 2023)
Director of Drug Metabolism and Pharmacokinetics @ (November 2014 - September 2020)
Scientific Director @ (January 2004 - October 2014)
Research Fellow @ (January 1996 - January 2003)
Analytical Associate and Contract Testing Liason @ (May 1987 - September 1991)
Mark Rose Education
The University of Kansas
Ph.D. (Pharmaceutical Chemistry)
1991-1996
Penn State University
BS (Chemistry)
1983-1987
North Hills High School
High School Diploma
1979-1983
Mark Rose Skills
Bioanalysis
Biomarker Development
Biomarkers
Biotechnology
Chemistry
Chromatography
Clinical Development
Consulting
DMPK
Drug Development
Drug Discovery
Drug Metabolism
Expert Reports
Expert Witness
GMP
Good Laboratory Practice (GLP)
HPLC
High-Performance Liquid Chromatography (HPLC)
LC-MS
Life Sciences
Liquid Chromatography-Mass Spectrometry (LC-MS)
Meeting Planning
Pharmaceutical Industry
Pharmaceutics
Pharmacokinetics
Project Management
Regulatory Compliance
Scientific Writing
Team Facilitation
author
Mark Rose Summary
Mark Rose, based in San Diego, CA, US, is currently a Vice President of DMPK and Nonclinical Safety at Spyre Therapeutics. Mark Rose brings experience from previous roles at DTx Pharma, Gossamer Bio, CHDI Management, Inc. and Amgen. Mark Rose holds a 1991 - 1996 Ph.D. in Pharmaceutical Chemistry @ The University of Kansas. With a robust skill set that includes Bioanalysis, Biomarker Development, Biomarkers, Biotechnology, Chemistry and more. Mark Rose has 1 emails on RocketReach.
Looking for a different Mark Rose?
Find contact details for 700 million professionals.